Overview

Persistent Lyme Empiric Antibiotic Study Europe

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to establish whether prolonged antibiotic treatment of patients diagnosed with proven or presumed PLD (as endorsed by the international ILADS guidelines) leads to better patient outcome than short-term treatment as endorsed by the Dutch CBO guidelines.
Phase:
Phase 4
Details
Lead Sponsor:
Radboud University
Collaborators:
Sint Maartenskliniek
ZonMw: The Netherlands Organisation for Health Research and Development
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ceftriaxone
Clarithromycin
Doxycycline
Hydroxychloroquine